[{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Moderator","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Gautam Mehta<\/i><\/u><\/presenter>. U.S. Food and Drug Administration, Silver Spring, MD","CSlideId":"","ControlKey":"d718cdba-25b7-4bbc-ab6f-f74d4810ef8b","ControlNumber":"8715","DisclosureBlock":"","End":"4\/12\/2022 2:31:00 PM","HasWebcast":null,"Highlights":[],"Id":"18222","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"1","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Gautam Mehta, MD","PresenterKey":"c49b3610-8d30-4885-93d2-30a4b0fbc591","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Moderator","SearchResultFooter":"","SearchResultHeader":"Apr 12 2022  2:30PM","SessionId":"490","SessionOnDemand":"False","SessionTitle":"Defining Clinical Benefit: Accelerated Approval in Precision Oncology","ShowChatLink":"false","Start":"4\/12\/2022 2:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Moderator","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Gautam Mehta<\/i><\/u><\/presenter>. U.S. Food and Drug Administration, Silver Spring, MD","CSlideId":"","ControlKey":"a3c42b58-6fdd-4179-b821-f16c872fc979","ControlNumber":"9680","DisclosureBlock":"","End":"4\/12\/2022 2:40:00 PM","HasWebcast":null,"Highlights":[],"Id":"21213","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"2","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Gautam Mehta, MD","PresenterKey":"c49b3610-8d30-4885-93d2-30a4b0fbc591","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Overview of the Accelerated Approval program in precision oncology","SearchResultFooter":"","SearchResultHeader":"Apr 12 2022  2:30PM","SessionId":"490","SessionOnDemand":"False","SessionTitle":"Defining Clinical Benefit: Accelerated Approval in Precision Oncology","ShowChatLink":"false","Start":"4\/12\/2022 2:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Overview of the Accelerated Approval program in precision oncology","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Vivek Subbiah<\/i><\/u><\/presenter>. MD Anderson Cancer Center, Houston, TX","CSlideId":"","ControlKey":"14240805-59d1-446d-9746-87363dc2e566","ControlNumber":"9198","DisclosureBlock":"<b>&nbsp;V. Subbiah, <\/b> <br><b>Eli Lilly\/ Loxo Oncology<\/b> Grant\/Contract, Yes. <br><b>Blueprint Medicines<\/b> Grant\/Contract, Yes. <br><b>Bayer<\/b> Grant\/Contract, No. <br><b>Novartis<\/b> Grant\/Contract, No. <br><b>Pfizer<\/b> Grant\/Contract, No. <br><b>Amgen<\/b> Grant\/Contract, No. <br><b>Exelixis<\/b> Grant\/Contract, No. <br><b>Helsin therapeutics<\/b> Grant\/Contract, No. <br><b>Turning Point therapeutics<\/b> Grant\/Contract, No. <br><b>Relay Therapeutics<\/b> Grant\/Contract, No.","End":"4\/12\/2022 2:50:00 PM","HasWebcast":null,"Highlights":[],"Id":"20614","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"3","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Vivek Subbiah, MD","PresenterKey":"af8da20e-d2a9-4ed0-8526-7504ffd27fce","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Designing clinical trials to demonstrate clinical benefit in precision oncology","SearchResultFooter":"","SearchResultHeader":"Apr 12 2022  2:30PM","SessionId":"490","SessionOnDemand":"False","SessionTitle":"Defining Clinical Benefit: Accelerated Approval in Precision Oncology","ShowChatLink":"false","Start":"4\/12\/2022 2:40:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Designing clinical trials to demonstrate clinical benefit in precision oncology","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Sara J. Whitlock<\/i><\/u><\/presenter>. RET Renegades, Dayton, OH","CSlideId":"","ControlKey":"79854cf9-4ce4-4927-beff-e8370ba3a63a","ControlNumber":"9199","DisclosureBlock":"","End":"4\/12\/2022 3:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"20616","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"4","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Sara Whitlock","PresenterKey":"61a75580-3dc4-4859-9181-3aa9c732dc2f","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Patient considerations in defining clinical benefit","SearchResultFooter":"","SearchResultHeader":"Apr 12 2022  2:30PM","SessionId":"490","SessionOnDemand":"False","SessionTitle":"Defining Clinical Benefit: Accelerated Approval in Precision Oncology","ShowChatLink":"false","Start":"4\/12\/2022 2:50:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Patient considerations in defining clinical benefit","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Diana Bradford<\/i><\/u><\/presenter>. U.S. Food and Drug Administration, Silver Spring, MD","CSlideId":"","ControlKey":"308eccff-cdf1-4404-961b-f393a9d184c3","ControlNumber":"9196","DisclosureBlock":"","End":"4\/12\/2022 3:10:00 PM","HasWebcast":null,"Highlights":[],"Id":"20612","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"5","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Diana Bradford, MD","PresenterKey":"54f747a6-4baa-44d5-b1c5-8a55d4922fda","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Review of FDA Accelerated Approvals of selpercatinib and pralsetinib","SearchResultFooter":"","SearchResultHeader":"Apr 12 2022  2:30PM","SessionId":"490","SessionOnDemand":"False","SessionTitle":"Defining Clinical Benefit: Accelerated Approval in Precision Oncology","ShowChatLink":"false","Start":"4\/12\/2022 3:00:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Review of FDA Accelerated Approvals of selpercatinib and pralsetinib","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Lori J. Wirth<\/i><\/u><\/presenter>. Massachusetts General Hospital, Boston, MA","CSlideId":"","ControlKey":"d63ca76b-f4dd-4bc7-80f2-a59c2362b613","ControlNumber":"9197","DisclosureBlock":"<b>&nbsp;L. J. Wirth, <\/b> <br><b>Merck<\/b> Grant\/Contract, No. <br><b>Loxo Oncology<\/b> Grant\/Contract, Yes. <br><b>Blueprint Medicines<\/b> Grant\/Contract, Yes. <br><b>Eisai<\/b> Grant\/Contract, No. <br><b>Eli Lilly<\/b> Grant\/Contract, Yes. <br><b>Bayer<\/b> Grant\/Contract, No. <br><b>Exelixis<\/b> Grant\/Contract, No. <br><b>Coherus<\/b> Grant\/Contract, No. <br><b>Morphic Therapeutic<\/b> Grant\/Contract, No. <br><b>PDS Biotechnology<\/b> Other, Data Safety Monitoring Committee, No.","End":"4\/12\/2022 3:20:00 PM","HasWebcast":null,"Highlights":[],"Id":"20613","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"6","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Lori Wirth","PresenterKey":"870c9580-0267-451f-a3db-fda60edb8dbb","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Confirmatory trial considerations after Accelerated Approval in precision oncology","SearchResultFooter":"","SearchResultHeader":"Apr 12 2022  2:30PM","SessionId":"490","SessionOnDemand":"False","SessionTitle":"Defining Clinical Benefit: Accelerated Approval in Precision Oncology","ShowChatLink":"false","Start":"4\/12\/2022 3:10:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Confirmatory trial considerations after Accelerated Approval in precision oncology","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"b9c82f80-774e-41fb-b05e-2e027c50daaa","ControlNumber":"9205","DisclosureBlock":"","End":"4\/12\/2022 4:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"20622","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"7","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Panel Discussion with Q&#38;A","SearchResultFooter":"","SearchResultHeader":"Apr 12 2022  2:30PM","SessionId":"490","SessionOnDemand":"False","SessionTitle":"Defining Clinical Benefit: Accelerated Approval in Precision Oncology","ShowChatLink":"false","Start":"4\/12\/2022 3:20:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Panel Discussion with Q&#38;A","Topics":null,"cSlideId":""}]